Clinical Trials Browser

Phase 1 × Triple Negative Breast Neoplasms × alovudine × Clear all

NCT01251874 2025-11-21

Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms